Cellular Dynamics International Inc (ICEL) financial statements (2021 and earlier)

Company profile

Business Address 525 SCIENCE DRIVE
MADISON, WI 53711
State of Incorp. WI
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments344147546269
Cash and cash equivalents344147546269
Receivables423332
Inventory, net of allowances, customer advances and progress billings444444
Inventory444444
Other undisclosed current assets111111
Total current assets:444855627075
Noncurrent Assets
Property, plant and equipment443321
Intangible assets, net (including goodwill)111111111111
Goodwill777777
Intangible assets, net (excluding goodwill)444444
Regulated entity, other noncurrent assets000000
Other noncurrent assets000000
Total noncurrent assets:151514141312
TOTAL ASSETS:596369758387
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities655465
Accounts payable222221
Accrued liabilities333233
Employee-related liabilities111111
Debt532100
Deferred revenue and credits443211
Other undisclosed current liabilities(1)(1)(1)(1)(1)(1)
Total current liabilities:131110774
Noncurrent Liabilities
Long-term debt and lease obligation8910111212
Long-term debt, excluding current maturities8910111212
Total noncurrent liabilities:8910111212
Total liabilities:212019181916
Stockholders' equity
Stockholders' equity attributable to parent384350586571
Common stock000000
Additional paid in capital175174174173172171
Accumulated deficit(138)(132)(124)(115)(107)(100)
Total stockholders' equity:384350586571
TOTAL LIABILITIES AND EQUITY:596369758387

Income statement (P&L) ($ in millions)

12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Revenues
(Revenue, Net)
744343
Cost of revenue
(Cost of Goods and Services Sold)
(1)(0)(1)(0)(1)(0)
Gross profit:633232
Operating expenses(12)(11)(12)(11)(11)(10)
Operating loss:(6)(8)(9)(8)(7)(8)
Nonoperating expense
(Other Nonoperating expense)
(0)(0)(0)(0)(0)(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)
Net loss:(7)(9)(9)(9)(8)(8)
Other undisclosed net income attributable to parent111111
Net loss available to common stockholders, diluted:(6)(8)(9)(8)(7)(7)

Comprehensive Income ($ in millions)

12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Net loss:(7)(9)(9)(9)(8)(8)
Comprehensive loss, net of tax, attributable to parent:(7)(9)(9)(9)(8)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: